. 2019 Jul 17;19:76. doi: 10.1186/s12902-019-0404-1

Table 1.

Baseline characteristics of type 2 diabetic patients with or without NAFLD

	Men			Women
	NAFLD(−)	NAFLD(+)	P	NAFLD(−)	NAFLD(+)	P
N	147	89	–	113	96	–
Age, years	57.6 ± 9.4	59.4 ± 9.8	0.169	61.1 ± 9.3	61.4 ± 8.7	0.834
Duration of diabetes, years	8.0 ± 7.1	6.1 ± 6.1	0.040	9.1 ± 6.6	7.7 ± 6.7	0.143
Duration of hypertension, years	3.1 ± 5.6	5.5 ± 7.1	0.05	5.0 ± 6.7	6.9 ± 7.0	0.045
Height, cm	167.9 ± 5.7	167.5 ± 5.1	0.596	154.9 ± 5.7	155.9 ± 5.7	0.201
Weight, cm	65.0 ± 9.1	73.6 ± 10.2	< 0.001	58.3 ± 9.1	63.3 ± 11.7	0.001
Body mass index, Kg/m²	23.0 ± 2.9	26.2 ± 3.4	< 0.01	24.3 ± 3.5	26.0 ± 4.4	0.002
Waist circumference, cm	85.6 ± 8.5	94.7 ± 8.4	< 0.001	86.8 ± 11.8	92.2 ± 11.4	0.001
Systolic blood pressure, mmHg	133.2 ± 21.8	138.4 ± 20.6	0.069	145.7 ± 26.4	140.8 ± 19.3	0.133
Diastolic blood pressure, mmHg	76.0 ± 12.5	80.7 ± 12.4	0.005	75.7 ± 12.8	76.8 ± 12.6	0.529
Hemoglobin A1c, mmol/L	10.3 ± 2.8	9.6 ± 2.2	0.005	9.4 ± 2.0	9.4 ± 2.1	0.901
Total cholesterol, mmol/L	4.2 ± 1.1	4.6 ± 1.3	0.016	4.6 ± 1.4	4.9 ± 1.4	0.050
Triglycerides, mmol/L	1.4 ± 0.9	2.3 ± 2.2	< 0.001	1.9 ± 2.1	2.3 ± 1.8	0.155
HDL-cholesterol, mmol/L	1.0 ± 0.3	0.9 ± 0.2	0.152	1.1 ± 0.3	1.0 ± 0.2	0.390
LDL-cholesterol, mmol/L	2.5 ± 0.9	2.6 ± 1.0	0.201	2.6 ± 0.9	2.8 ± 0.9	0.061
ALT, IU/L	24.2 ± 14.5	28.5 ± 18.2	0.047	20.8 ± 11.8	25.0 ± 14.0	0.039
AST, IU/L	22.6 ± 10.5	25.4 ± 11.5	0.054	22.1 ± 9.7	25.0 ± 11.2	0.049
Current smoking, %	44.2	43.8	1.000	1.8	0	0.501
Current drinking, %	10.2	11.2	0.829	0	0	1.000
Menopause, %	–	–	–	89.2	91.3	0.645
Medications
Statin (%)	8.2	11.1	0.717	10.4	8.3	1.000
Metformin (%)	53.1	61.1	0.512	50.0	61.1	0.378
Insulin (%)	65.3	50.0	0.185	70.8	63.9	0.637
ASM, kg	21.5 ± 2.8	22.6 ± 2.7	0.002	15.4 ± 2.4	15.7 ± 2.6	0.369
Visceral fat area, cm²	95.7 ± 25.6	120.7 ± 36.0	< 0.001	104.7 ± 32.9	121.0 ± 28.8	< 0.001
SVR, g/cm²	238.7 ± 73.3	197.8 ± 57.4	< 0.001	160.0 ± 58.0	136.7 ± 38.1	0.001